Drawing for MEDICAGO

USPTO serial 86878509

MEDICAGO

Reviewed by CopyMark Law Group

Reg. 6010582Status 710
Filing date
Status date
Registration date
Mar 17, 2020
Examiner
SHINER, MARK W
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with MEDICAGO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michelle P. Ciotola

Michelle P. Ciotola CANTOR COLBURN LLP20 Church StreetFloor 22Hartford, CT 06103-1253

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and medicinal preparations and substances, namely, human vaccines, therapeutic proteins and antibodies for treatment of infectious diseases, chronic diseases and cancerSECTION 8 - CANCELLED—
040Manufacture of pharmaceuticals, pharmaceutical ingredients, vaccines and antibodies for othersSECTION 8 - CANCELLED—
042Research and development in the field of vaccines, recombinant proteins and antibodies for therapeutic and prophylactic use; high throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; product research and development and scientific research in the field of protein production using recombinant technologies through transient expression in plants; medical and scientific research services relating to infectious diseases; medical and scientific research regarding clinical trial studies on new vaccine candidates; development of pharmaceuticals, pharmaceutical ingredients, vaccines, and antibodiesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 2, 2026C8..CANCELLED SEC. 8 (6-YR)—
Mar 17, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Aug 11, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 11, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 11, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 4, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 4, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 4, 2023ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
May 4, 2023EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
May 4, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 4, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 4, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 17, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 6, 2020DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Feb 6, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 15, 2020IUCNNOTICE OF ALLOWANCE CANCELLED—
Jan 15, 2020EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Jan 14, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 19, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 19, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 30, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 10, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 2, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 2, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 1, 2019ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jul 22, 2019GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Jul 22, 2019GNSIINQUIRY TO SUSPENSION E-MAILED—
Jul 22, 2019CNSISUSPENSION INQUIRY WRITTEN—
Jan 18, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jan 18, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Jan 18, 2019CNSLSUSPENSION LETTER WRITTEN—
Jan 18, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 18, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 16, 2019ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Aug 15, 2018GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Aug 15, 2018GNSIINQUIRY TO SUSPENSION E-MAILED—
Aug 15, 2018CNSISUSPENSION INQUIRY WRITTEN—
Feb 15, 2018GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Feb 15, 2018GNSLLETTER OF SUSPENSION E-MAILED—
Feb 15, 2018CNSLSUSPENSION LETTER WRITTEN—
Aug 15, 2017GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Aug 15, 2017GNSLLETTER OF SUSPENSION E-MAILED—
Aug 15, 2017CNSLSUSPENSION LETTER WRITTEN—
Aug 9, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 9, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 7, 2017ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Mar 15, 2017GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Mar 15, 2017GNSIINQUIRY TO SUSPENSION E-MAILED—
Mar 15, 2017CNSISUSPENSION INQUIRY WRITTEN—
Sep 15, 2016GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Sep 15, 2016GNSLLETTER OF SUSPENSION E-MAILED—
Sep 15, 2016CNSLSUSPENSION LETTER WRITTEN—
Sep 15, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 15, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 10, 2016ALIEASSIGNED TO LIE—
Sep 2, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 4, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 2, 2016DOCKASSIGNED TO EXAMINER—
Jan 22, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 21, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance